|
""Comparative gene resequencing in mouse cancer models""
|
5K08CA160658-04
|
$180,360
|
$180,360
|
MCFADDEN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQA1) FMRI Neurofeedback and Descision-Making in Habitual Cigarette Smokers
|
1R21CA190093-01
|
$196,664
|
$196,664
|
WILSON, STEPHEN
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
(PQA2) Elucidating the link between obesity, inflammation and estrogen signaling
|
1R21CA184611-01
|
$167,204
|
$167,204
|
STABILE, LAURA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQA3) NEURAL PREDICTORS OF SELF-REGULATION OF SMOKING URGES AT A STRESSFUL MOMEN
|
1R21CA184834-01
|
$205,368
|
$205,368
|
LIM, SEUNG LARK
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
|
(PQA3) Smartphone delivered attentional bias modification training for smokers
|
1R01CA184781-01
|
$370,397
|
$370,397
|
ROBINSON, JASON
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
|
1R01CA185020-01
|
$325,183
|
$325,183
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
5R01CA180126-02
|
$679,887
|
$679,887
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(PQB6) Accurate Comparative Genome-wide Analysis of Primary Tumors and Metastases
|
5R21CA180016-02
|
$166,671
|
$83,336
|
WOTTON, DAVID
|
UNIVERSITY OF VIRGINIA
|
|
(PQC1) PLK1 And EPHX3 Promotion Of Genomic Instability In Bronchial Dysplasia
|
1R21CA190124-01
|
$212,834
|
$212,834
|
MERRICK, DANIEL
|
UNIVERSITY OF COLORADO DENVER
|
|
(PQD6) Mechanistic insights into treatment of cancer anorexia and cachexia
|
1R21CA184630-01
|
$227,070
|
$113,535
|
SCHWARTZ, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
|
(PQD6)The Role of Immune Homeostasis in Protection from Cancer Cachexia
|
1R01CA185349-01
|
$325,000
|
$325,000
|
DAVIES, JOANNA
|
SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$1,030,755
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
2/2 The TREND Partnership: Tobacco Research and Education to Eliminate Disparitie
|
1P20CA192991-01
|
$209,665
|
$209,665
|
OSTROFF, JAMIE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$825
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
402 -- TITLE: MODIFICATION TO EXERCISE OPTION PERIOD 5. CONTRACTOR: WESTAT INTERN
|
N1CN25476A
|
$1,728,293
|
$1,728,293
|
UNKNOWN, UNKNOWN
|
WESTAT, INC.
|
|
4D Robust Optimization in Intensity-Modulated Proton Therapy
|
5K25CA168984-03
|
$99,908
|
$49,954
|
LIU, WEI
|
MAYO CLINIC ARIZONA
|
|
A cohort mortality study with a nested case-control study of lung cancer and diesel exhaust among non-metal miners
|
ZIA CP010120 - 02091
|
$375,327
|
$375,327
|
Silverman, Debra
|
DCEG (NCI)
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 - 02060
|
$286,453
|
$57,291
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A Community Trial to Speed the Diffusion of Smoke Free Multiunit Housing Policies
|
5R01CA151953-04
|
$494,386
|
$494,386
|
TRAVERS, MARK
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A Cyber-Informatics Approach to Studying Migration and Environmental Cancer Risk
|
5R01CA170508-03
|
$380,613
|
$190,307
|
TOURASSI, GEORGIA
|
UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB
|
|
A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC
|
5R01CA157409-03
|
$607,647
|
$607,647
|
HOLLEN, PATRICIA
|
UNIVERSITY OF VIRGINIA
|
|
A dual acting drug for enhancing radiotherapeutic benefit
|
1R43CA180316-01A1
|
$209,208
|
$209,208
|
NORRIS, ANDREW
|
BCN BIOSCIENCES, LLC
|
|
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
|
2R42CA156930-02
|
$534,844
|
$534,844
|
JONES, BARRY
|
ARISAPH PHARMACEUTICALS, INC.
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-03
|
$1,262,499
|
$252,500
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A genomewide study of lung cancer in never smokers
|
7R01CA149462-05
|
$435,109
|
$435,109
|
GORLOVA, OLGA
|
DARTMOUTH COLLEGE
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
1R01CA188446-01
|
$740,000
|
$740,000
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yuan China: PAH Exposure Genetic Susceptibility and Lung Cancer
|
ZIA CP010121 - 10349
|
$104,426
|
$104,426
|
Lan, Qing
|
DCEG (NCI)
|
|
A new model for discovering genetic determinants of angiogenesis and the effect o
|
1R21CA178550-01A1
|
$165,300
|
$165,300
|
INNOCENTI, FEDERICO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer
|
5R01CA166376-03
|
$374,383
|
$374,383
|
NGUYEN, DON
|
YALE UNIVERSITY
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$420,465
|
$21,023
|
Merlino, Glenn
|
CCR (NCI)
|
|
A Novel Trial of Smokeless Tobacco for Cessation Induction in Unmotivated Smokers
|
5R01CA154992-04
|
$428,878
|
$428,878
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
1R01CA187143-01
|
$522,597
|
$522,597
|
BADR, HODA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A RETAIL POLICY LABORATORY: MODELING IMPACT OF RETAILER REDUCTION ON TOBACCO USE
|
5R21CA172938-02
|
$148,211
|
$148,211
|
LUKE, DOUGLAS
|
WASHINGTON UNIVERSITY
|
|
A Role for AMH Autocrine Signaling in NSCLC
|
1R21CA181287-01A1
|
$191,104
|
$191,104
|
GOLEMIS, ERICA
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer
|
7R01CA164447-04
|
$248,800
|
$248,800
|
BROWN, KATHLYNN
|
SRI INTERNATIONAL
|
|
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer
|
5R01CA164447-03
|
$115,937
|
$115,937
|
BROWN, KATHLYNN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
A Test of Two Clinical Methods to Prompt a Quit Attempt Among Tobacco Smokers
|
5R01CA163176-03
|
$378,123
|
$378,123
|
HUGHES, JOHN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-05S1
|
$65,000
|
$16,250
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-05S2
|
$200,000
|
$50,000
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
5U54CA153499-05
|
$972,136
|
$243,034
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
$53,831
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$6,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$595,976
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acceptance & Commitment Therapy for Smoking Cessation
|
5R01CA151251-05
|
$586,179
|
$586,179
|
BRICKER, JONATHAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)
|
5R01CA150980-03
|
$478,893
|
$239,447
|
ENG, EUGENIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$107,428
|
$21,486
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Activating Bax as a therapeutic strategy for lung cancer
|
5R01CA175003-02
|
$300,653
|
$300,653
|
LI, CHI
|
UNIVERSITY OF LOUISVILLE
|
|
Activation of Cyclin-Dependent Kinases by Fructose-2,6-Bisphosphate
|
5R01CA149438-04
|
$301,913
|
$301,913
|
CHESNEY, JASON
|
UNIVERSITY OF LOUISVILLE
|
|
ACTIVITY-BASED KINASE DISCOVERY IN SMALL CELL LUNG CANCER
|
5R21CA169979-02
|
$182,868
|
$182,868
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Adolescent Smoking Cessation in Pediatric Primary Care
|
5R01CA140576-05
|
$405,576
|
$405,576
|
KLEIN, JONATHAN
|
AMERICAN ACADEMY OF PEDIATRICS
|
Total relevant funding to Lung for this search: $254,158,823
|